Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simtuzumab in HIV/HCV with Liver Fibrosis
NCT01707472Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2012
- Primary completion
- Oct 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of simtuzumab in Liver Fibrosis (LF), sponsored by Gilead Sciences. Started Oct 2012; status: completed.
02
Drugs
simtuzumab
03
Conditions
Liver Fibrosis (LF)
Beyond the preview
Go deeper on NCT01707472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01707472.